OMA1相关文献与解析，生知库 | 链接生命科学的每一步

Kroczek Lara, Nolte Hendrik, Lasarzewski Yvonne, Agrawal Ishita, MoliniÃ© Thibaut, Curbelo PiÃ±ero Daniel, Lemke Kathrin, Rugarli Elena, Langer Thomas

OMA1

线粒体

发表日期：2026

文献求助收藏

circOMA1 delivered by exosomes regulates DRD2âmediated prolactinoma resistance.

外泌体递送的 circOMA1 调节 DRD2 介导的催乳素瘤耐药性。

期刊:International Journal of Molecular Medicine

影响因子:5.8

doi:10.3892/ijmm.2026.5812

Rao Qing, Zhu Dimin, Wang Zongming, Zhang Shaolin, Li Xueli, Tagilapalli Shashikiran, Wang Nan, Hu Weiyu, Chen Wenli, Zhu Yonghong

Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentation

经顺铂化疗后存活的癌细胞会增加应激诱导的OMA1活性和线粒体碎片化

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-33677-1

Li, Melvin; McCullum, Chenille A; Rolle, Louis T A; Ni, Qin; Ge, Zhuoxu; Sun, Sean X; Pienta, Kenneth J; Amend, Sarah R

Correction: Mechanism underlying the role of the circRNA OMA1/miR-654-3p/RAF1 axis in children with inflammatory bowel disease

更正：circRNA OMA1/miR-654-3p/RAF1轴在儿童炎症性肠病中的作用机制

期刊:Cytotechnology

影响因子:1.7

doi:10.1007/s10616-025-00770-2

Zhang, Ping; Wang, Zhenhui; Xu, Yufen; Wu, Meirong

Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentation

经顺铂化疗后存活的癌细胞会增加应激诱导的OMA1活性和线粒体碎片化

期刊:

影响因子:

doi:10.1101/2025.09.29.679325

Li, Melvin; McCullum, Chenille A; Rolle, Louis T A; Ni, Qin; Ge, Zhuoxu; Sun, Sean X; Pienta, Kenneth J; Amend, Sarah R

Opa1 processing is dispensable in mouse development but is protective in mitochondrial cardiomyopathy

Opa1 加工在小鼠发育过程中并非必需，但对线粒体心肌病却具有保护作用

期刊:Science Advances

影响因子:11.7

doi:10.1126/sciadv.adp0443

Sofia Ahola, Lilli A Pazurek, Fiona Mayer, Philipp Lampe, Steffen Hermans, Lore Becker, Oana V Amarie, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabe de Angelis, Dietmar Riedel, Hendrik Nolte, Thomas Langer

Correction: OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape

更正：OMA1 与 HSPA9 竞争性结合，促进线粒体自噬，并激活 cGAS-STING 通路，从而介导 GBM 的免疫逃逸。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2023-008718corr1

OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape

OMA1与HSPA9竞争性结合，促进线粒体自噬，并激活cGAS-STING通路，从而介导胶质母细胞瘤的免疫逃逸。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.3

doi:10.1136/jitc-2023-008718

Wen de Zhu #,Jin Rao #,Li Hua Zhang,Ka Ming Xue,Lin Li,Jun Jun Li,Qian Zhi Chen #,Rong Fu #

Excessive processing and acetylation of OPA1 aggravate age-related hearing loss via the dysregulation of mitochondrial dynamics

OPA1 的过度加工和乙酰化会通过线粒体动力学失调加剧与年龄相关的听力损失

期刊:Aging Cell

影响因子:8

doi:10.1111/acel.14091

Andi Zhang, Yi Pan, Hao Wang, Rui Ding, Tianyuan Zou, Dongye Guo, Yilin Shen, Peilin Ji, Weiyi Huang, Qing Wen, Quan Wang, Haixia Hu, Jichang Wu, Mingliang Xiang, Bin Ye

OMA1 clears traffic jam in TOM tunnel in mammals

OMA1 清除哺乳动物 TOM 隧道中的交通拥堵

期刊:Journal of Cell Biology

影响因子:6.4

doi:10.1083/jcb.202403190

Sekine, Shiori; Sekine, Yusuke

OMA1

发表日期：2024

文献求助收藏

Stress adaptation of mitochondrial protein import by OMA1-mediated degradation of DNAJC15.

OMA1介导的DNAJC15降解对线粒体蛋白输入的应激适应。

circOMA1 delivered by exosomes regulates DRD2âmediated prolactinoma resistance.

外泌体递送的 circOMA1 调节 DRD2 介导的催乳素瘤耐药性。

Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentation

经顺铂化疗后存活的癌细胞会增加应激诱导的OMA1活性和线粒体碎片化

Correction: Mechanism underlying the role of the circRNA OMA1/miR-654-3p/RAF1 axis in children with inflammatory bowel disease

更正：circRNA OMA1/miR-654-3p/RAF1轴在儿童炎症性肠病中的作用机制

Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentation

经顺铂化疗后存活的癌细胞会增加应激诱导的OMA1活性和线粒体碎片化

Opa1 processing is dispensable in mouse development but is protective in mitochondrial cardiomyopathy

Opa1 加工在小鼠发育过程中并非必需，但对线粒体心肌病却具有保护作用

Correction: OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape

更正：OMA1 与 HSPA9 竞争性结合，促进线粒体自噬，并激活 cGAS-STING 通路，从而介导 GBM 的免疫逃逸。

OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape

OMA1与HSPA9竞争性结合，促进线粒体自噬，并激活cGAS-STING通路，从而介导胶质母细胞瘤的免疫逃逸。

Excessive processing and acetylation of OPA1 aggravate age-related hearing loss via the dysregulation of mitochondrial dynamics

OPA1 的过度加工和乙酰化会通过线粒体动力学失调加剧与年龄相关的听力损失

OMA1 clears traffic jam in TOM tunnel in mammals

OMA1 清除哺乳动物 TOM 隧道中的交通拥堵

Stress adaptation of mitochondrial protein import by OMA1-mediated degradation of DNAJC15.

OMA1介导的DNAJC15降解对线粒体蛋白输入的应激适应。

circOMA1 delivered by exosomes regulates DRD2âmediated prolactinoma resistance.

外泌体递送的 circOMA1 调节 DRD2 介导的催乳素瘤耐药性。

Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentation

经顺铂化疗后存活的癌细胞会增加应激诱导的OMA1活性和线粒体碎片化

Correction: Mechanism underlying the role of the circRNA OMA1/miR-654-3p/RAF1 axis in children with inflammatory bowel disease

更正：circRNA OMA1/miR-654-3p/RAF1轴在儿童炎症性肠病中的作用机制

Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentation

经顺铂化疗后存活的癌细胞会增加应激诱导的OMA1活性和线粒体碎片化

Opa1 processing is dispensable in mouse development but is protective in mitochondrial cardiomyopathy

Opa1 加工在小鼠发育过程中并非必需，但对线粒体心肌病却具有保护作用

Correction: OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape

更正：OMA1 与 HSPA9 竞争性结合，促进线粒体自噬，并激活 cGAS-STING 通路，从而介导 GBM 的免疫逃逸。

OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape

OMA1与HSPA9竞争性结合，促进线粒体自噬，并激活cGAS-STING通路，从而介导胶质母细胞瘤的免疫逃逸。

Excessive processing and acetylation of OPA1 aggravate age-related hearing loss via the dysregulation of mitochondrial dynamics

OPA1 的过度加工和乙酰化会通过线粒体动力学失调加剧与年龄相关的听力损失

OMA1 clears traffic jam in TOM tunnel in mammals

OMA1 清除哺乳动物 TOM 隧道中的交通拥堵

circOMA1 delivered by exosomes regulates DRD2âmediated prolactinoma resistance.